Not applicableStudy completedNCT00410293What this trial is testingNT-proBNP in Acute Dyspnea: Effects on Treatment, Hospitalisation and CostsWho this might be right forHeart FailureDyspnea Erasmus Medical Center 500
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT02435849What this trial is testingStudy of Efficacy and Safety of CTL019 in Pediatric ALL PatientsWho this might be right forB-cell Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 80
Not applicableUnknownNCT05059847What this trial is testingImpact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia AdultsWho this might be right forAcute Lymphoblastic Leukemia, Adult B-Cell Hospital General de Mexico 114
Testing effectiveness (Phase 2)Looking for participantsNCT07008885What this trial is testingBCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALLWho this might be right forAcute Lymphocytic Leukemia Chinese PLA General Hospital 30
Early research (Phase 1)UnknownNCT04289220What this trial is testingAnti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic LeukemiaWho this might be right forB Cell LymphomaB-cell Acute Lymphoblastic Leukemia Yan'an Affiliated Hospital of Kunming Medical University 10
Testing effectiveness (Phase 2)UnknownNCT03265106What this trial is testingA Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma SubjectsWho this might be right forRelapsed B-cell Acute Lymphoblastic Leukemia, ChildhoodRefractory B-cell Acute Lymphoblastic Leukemia, ChildhoodRelapsed/Refractory B-cell Lymphoma, Childhood Shenzhen BinDeBio Ltd. 20
Very early researchLooking for participantsNCT07695012What this trial is testingCAR-T Cell Therapy for ALLWho this might be right forRelapsed Acute Lymphoblastic Leukemia (ALL) Dr. Zaineb Akram 10
Testing effectiveness (Phase 2)Ended earlyNCT05086315What this trial is testingFirst-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Who this might be right forAcute Lymphocytic LeukaemiaAcute Myeloid Leukaemia RefractoryMyelodysplastic Syndromes+1 more Sanofi 101
Testing effectiveness (Phase 2)Ended earlyNCT02877082What this trial is testingTacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant PatientsWho this might be right forAcute LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+9 more Emory University 5
Large-scale testing (Phase 3)Study completedNCT03476239What this trial is testingEfficacy and Safety of the BiTE Antibody Blinatumomab in Chinese Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic Leukemia Amgen 121
Not applicableStudy completedNCT00080873What this trial is testingTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationWho this might be right forKidney CancerLeukemiaLymphoma+3 more Children's Oncology Group 195
Testing effectiveness (Phase 2)Ended earlyNCT01044745What this trial is testingRituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more University of Nebraska 20
Not applicableActive Not RecruitingNCT04167683What this trial is testingMuscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell TransplantWho this might be right forHematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more Rigshospitalet, Denmark 144
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Ended earlyNCT00324324What this trial is testingMoxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 240
Not applicableStudy completedNCT00002485What this trial is testingDevelopment of Strategies to Increase Enrollment in Clinical Trials for Children With CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more Children's Oncology Group 359
Early research (Phase 1)Looking for participantsNCT04318678What this trial is testingCD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)Who this might be right forAML/MDSB-ALLT-ALL+1 more St. Jude Children's Research Hospital 108
Testing effectiveness (Phase 2)Looking for participantsNCT04150497What this trial is testingPhase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)Who this might be right forB-cell Acute Lymphoblastic Leukemia Cellectis S.A. 52
Early research (Phase 1)Looking for participantsNCT06326008What this trial is testingSafety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-derived CD22 CAR Therapy for r/r B-ALL: a Clinical TrialWho this might be right forB-cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia, in Relapse Beijing GoBroad Hospital 48